A South Dakota bio-tech firm is using blood byproducts from cattle to develop new ways of treating injured soldiers on the battlefield.
The technology could also save lives after natural disasters such as the Jan. 12 earthquake in Haiti, company executives say.
"It could help a lot of people in mass casualty situations where blood loss and wounds that need to get healed are a problem," says Steve Tye, vice president of operations for IKOR Inc. "This is a drug that can be stored for years so it can be delivered on the first flights out there."
IKOR aims to use hemoglobin from cattle as its raw material to develop blood replacement products for injured soldiers, Tye says. The goal is to heal their wounds more quickly and effectively, partly because the products can help deliver oxygen to the wound.
To read the entire article, link here.